People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Circular Genomics Inc. | — | Biotechnology | Series A | $12.6M | $54.7M | 2021 |
Nikolaos Mellios at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nikolaos Mellios on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Blivin | 1 | 14 |
| Waneta Tuttle | 1 | 6 |
| Joseph Cook III | 1 | 4 |
| Cathy Petti | 1 | 2 |
| Alexander Hafez | 1 | 2 |
| Kosmas Karadimitriou | 1 | 1 |
| Fortunado Rocca | 1 | 1 |
| Paul Sargeant | 1 | 1 |
| Stephen McKernan | 1 | 1 |
| Blivin David | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.